市場調査レポート
商品コード
1071419

血管造影装置:市場予測(2022年~2027年)

Angiography Equipment Market - Forecasts from 2022 to 2027

出版日: | 発行: Knowledge Sourcing Intelligence | ページ情報: 英文 131 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
血管造影装置:市場予測(2022年~2027年)
出版日: 2022年03月01日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 131 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の血管造影装置の市場規模は、2020年に125億1,300万米ドルとなり、予測期間中に7.92%のCAGRで拡大し、2027年に213億3,400万米ドルになると予測されています。同市場を牽引する要因には、世界中でがんや心血管疾患の発生率が増加していることと相まって、高い有病率などが挙げられます。

高齢者人口の増加や世界の肥満人口の増加は、血管造影を必要とする疾患の急増につながっています。さらに、さまざまな先進地域における製品の承認に関する政府の有利な規制も、世界市場の成長を促進すると予想されます。また、低侵襲手術への嗜好の変化により、血管造影システムに対する需要が高まっています。さらに、血管造影装置における技術革新の進展は医療プロセスを向上させるため、市場の成長に貢献すると予想されます。しかし、先進的な血管造影装置の調達と使用に伴う高いコストが、世界市場の成長を阻害する主な要因となっています。

当レポートでは、血管造影装置の世界市場を調査し、市場規模や予測、市場の促進要因および課題、市場動向、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション

第2章 調査手法

  • 調査データ
  • 仮定

第3章 エグゼクティブサマリー

  • 調査のハイライト

第4章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • ポーターのファイブフォース分析
    • エンドユーザーの交渉力
    • 買い手の交渉力
    • 新規参入者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • 業界のバリューチェーン分析

第5章 血管造影装置市場分析:技術別

  • イントロダクション
  • X線血管造影
  • コンピュータ断層撮影血管造影
  • 磁気共鳴血管造影

第6章 血管造影装置市場分析:処置別

  • イントロダクション
  • 冠状
  • 血管内
  • 神経血管

第7章 血管造影装置市場分析:用途別

  • イントロダクション
  • 診断
  • 治療

第8章 血管造影装置市場分析:エンドユーザー別

  • イントロダクション
  • 病院と診療所
  • 調査研究機関
  • 診断センター

第9章 血管造影装置市場分析:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • その他
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • 台湾
    • タイ
    • インドネシア
    • その他

第10章 競合環境と分析

  • 主要企業と戦略分析
  • 新興企業と市場の収益性
  • 合併、買収、合意、およびコラボレーション
  • ベンダー競争力マトリックス

第11章 企業プロファイル

  • GE Healthcare
  • Siemens Healthcare
  • Philips Healthcare
  • Shimadzu Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cordis Corporation
  • AngioDynamics, Inc.
目次
Product Code: KSI061611893

The angiography equipment market is evaluated at US$12.513 billion for the year 2020 and is projected to grow at a CAGR of 7.92% to reach the market size of US$21.334 billion by the year 2027.

The high prevalence, coupled with the increasing incidence of cancer and cardiovascular diseases around the world, is one of the major factors anticipated to drive the growth of the angiography equipment market during the forecast period. The rise in the geriatric population and an increase in the growing number of obese people around the world are leading to a surge in diseases that require angiography. Furthermore, favourable government regulations for the approval of the product in the various developed regions are also expected to fuel the growth of the global market. There is also a growing demand for angiography systems due to a shift in preference towards minimally invasive surgeries. Moreover, growing innovations in angiography equipment are improving the medical process and, hence, are anticipated to contribute to the market growth. However, high costs associated with the procurement and use of technologically advanced angiography equipment are a major factor likely to hamper the growth of the global market.

The recent outbreak of the novel coronavirus disease has a negative impact on the angiography equipment market. The pandemic shifted the major focus of the healthcare system towards COVID-19, and as part of the COVID-19 restrictions, a large number of procedures and surgeries had to be cancelled in many parts of the world, which led to a decline in the angiography equipment market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

The increasing prevalence of cardiovascular diseases

The world is witnessing a surge in the number of cases of cardiovascular diseases over the years, which is leading to an increased demand for angiography equipment and is projected to boost the market growth during the forecast period. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990, which nearly doubled to 523 million in 2019. It also states that the number of people who died from cardiovascular disease increased from 12.1 million in 1990 to 18.6 million in 2019. The American Heart Association (AHA) predicts that 45% of the population of the United States will have at least one heart-related problem. It also estimates that the costs related to cardiovascular diseases will increase by 100% between 2016 and 2035. According to WHO, cardiovascular disease has the highest share in the list of leading causes of death. The organisation states that cardiovascular diseases caused 17.9 million deaths in 2019 around the world and represented 32% of all deaths worldwide. Premature deaths are also increasing with the growing prevalence of heart diseases, with 38% of all the 17 million premature deaths due to non-communicable diseases caused by CVDs in 2019. The growing trend of CVDs is projected to continue in the coming years as well and is anticipated to drive the market growth of angiography equipment.

Increase in innovation

The rising innovations in the market and the launch of advanced angiography equipment by the market players are widening the scope of angiography equipment and are anticipated to propel the growth of angiography equipment during the assessment period. The medical device company Kinepict Health has developed Kinepict Medical Imaging Tool (KMIT) software which uses the Digital Variance Angiography (DVA) technology and provides superior image quality compared to the conventionally-used technologies. The FDA has given clearance for it in March 2020, which has allowed it to be launched in the U.S. market. Furthermore, GE Healthcare has introduced the Allia IGS 7 angiography system at the Radiological Society of North America (RSNA) 2020 virtual meeting. The system makes use of artificial intelligence and allows better use of rotational angiography. Several other innovative products are being launched by various companies, leading to improvements in the angiography process and are anticipated to spur the growth of angiography equipment during the forecast period.

North America held a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to the presence of a large number of market leaders, coupled with a high prevalence of cardiovascular diseases. Also, the presence of an advanced healthcare system allows a larger adoption of new and advanced angiography equipment. The Asia Pacific region is anticipated to witness substantial growth due to the rising number of cases of CVDs, coupled with increased investments in the healthcare sector in the region, which will lead to the availability of requisite healthcare facilities.

Market Segmentation

  • By Technology

X-Ray Angiography

Computed Tomography Angiography

Magnetic Resonance Angiography

  • By Procedure

Coronary

Endovascular

Neurovascular

  • By Application

Diagnostic

Therapeutic

  • By End-User

Hospitals and Clinics

Research Institutes

Diagnostic Centers

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Spain
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Angiography Equipment Market Analysis, by Technology

  • 5.1. Introduction
  • 5.2. X-Ray Angiography
  • 5.3. Computed Tomography Angiography
  • 5.4. Magnetic Resonance Angiography

6. Angiography Equipment Market Analysis, by Procedure

  • 6.1. Introduction
  • 6.2. Coronary
  • 6.3. Endovascular
  • 6.4. Neurovascular

7. Angiography Equipment Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Diagnostic
  • 7.3. Therapeutic

8. Angiography Equipment Market Analysis, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Research Institutes
  • 8.4. Diagnostic Centers

9. Angiography Equipment Market Analysis, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. UK
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Taiwan
    • 9.6.6. Thailand
    • 9.6.7. Indonesia
    • 9.6.8. Others

10. Competitive Environment and Analysis

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativenessness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. Company Profiles 

  • 11.1. GE Healthcare
  • 11.2. Siemens Healthcare
  • 11.3. Philips Healthcare
  • 11.4. Shimadzu Corporation
  • 11.5. Canon Medical Systems Corporation
  • 11.6. Carestream Health
  • 11.7. B. Braun Melsungen AG
  • 11.8. Boston Scientific Corporation
  • 11.9. Cordis Corporation
  • 11.10. AngioDynamics, Inc.